Eusa Pharma Is A Global Biopharmaceutical Company Focused On Oncology And Rare Diseasesfounded In 2006 And Re Established As An Independent Entity In 2015Eusa Pharma Develops And Commercializes Specialty Hospital Productsthe Company Has A Strong Portfolio Of Approved Products And Aims To Expand Through Acquisitions And In Licensing With Operations In The Us And Europeeusa Pharma Has A Distribution Network That Spans Approximately 40 Countriesthe Company Is Part Of Recordati Rare Diseaseswhich Enhances Its Capabilities In Addressing Rare Diseaseseusa Pharma Is Supported By Significant Funding From Leading Healthcare Growth Equity Investorsenabling It To Pursue Ambitious Growth Strategies
